(Q46809075)

25 December 2017

title

Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease (English)

1 reference

25 December 2017

non-alcoholic fatty liver

main subject

steatohepatitis

0 references

glucose

0 references

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

John Willy Haukeland

1

1 reference

25 December 2017

Zbigniew Konopski

2

1 reference

25 December 2017

Paul Linnestad

3

1 reference

25 December 2017

Shafiullah Azimy

4

1 reference

25 December 2017

Else Marit Løberg

5

1 reference

25 December 2017

Terese Haaland

6

1 reference

25 December 2017

Kåre Birkeland

7

1 reference

25 December 2017

Kristian Bjøro

8

1 reference

25 December 2017

publication date

1 December 2005

1 reference

25 December 2017

Scandinavian Journal of Gastroenterology

published in

1 reference

25 December 2017

volume

40

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

1469-1477

1 reference

25 December 2017

Nonalcoholic fatty liver disease

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Long term prognosis of fatty liver: risk of chronic liver disease and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Non-alcoholic steatohepatitis in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Prevalence and Predictors of Asymptomatic Liver Disease in Patients Undergoing Gastric Bypass Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Autoantibodies in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Iron metabolism and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Hepatic iron and nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520500264953

10.1080/00365520500264953

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16293559

1 reference

25 December 2017